Skip to main content

RAPS 2024 Regulatory Intelligence Conference Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Title

Browse by Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

A
A Strategic Approach: Best Practices for Commenting on Draft FDA Guidance Documents for Drug and Device Companies
Favorite

Gopal Abbineni, MS, PhD (he/him/his) – Bayer ### 2277708###Presenter###Director###Bayer###
Presenter: Gopal Abbineni, MS, PhD (he/him/his) – Bayer
### he/him/his @@@ Andrew J. Emmett, RAC, MPH (he/him/his) – Pfizer ### 2316019###Presenter###Executive Director, US Regulatory Policy & Global Intelligence###Pfizer###
Presenter: Andrew J. Emmett, RAC, MPH (he/him/his) – Pfizer
### he/him/his
Advancing Policy Initiatives: The Regulatory Policy Value of Drug and Device Companies' Participation in Trade Associations and Industry Consortia
Favorite

Diana Salditt, FRAPS – Salditt Regulatory Consulting LLC ### 609884###Presenter###Principal Consultant###Salditt Regulatory Consulting LLC###
Presenter: Diana Salditt, FRAPS – Salditt Regulatory Consulting LLC
### @@@ Stephanie S. Kelly, JD, MS – Kyowa Kirin ### 2289417###Presenter###GRA, Global Head of Regulatory Intelligence and Policy ###Kyowa Kirin###
Presenter: Stephanie S. Kelly, JD, MS – Kyowa Kirin
###